1. Home
  2. AKRO vs ATSG Comparison

AKRO vs ATSG Comparison

Compare AKRO & ATSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • ATSG
  • Stock Information
  • Founded
  • AKRO 2017
  • ATSG 1980
  • Country
  • AKRO United States
  • ATSG United States
  • Employees
  • AKRO N/A
  • ATSG N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • ATSG Air Freight/Delivery Services
  • Sector
  • AKRO Health Care
  • ATSG Consumer Discretionary
  • Exchange
  • AKRO Nasdaq
  • ATSG Nasdaq
  • Market Cap
  • AKRO 2.8B
  • ATSG 1.5B
  • IPO Year
  • AKRO 2019
  • ATSG N/A
  • Fundamental
  • Price
  • AKRO $37.63
  • ATSG N/A
  • Analyst Decision
  • AKRO Strong Buy
  • ATSG Buy
  • Analyst Count
  • AKRO 9
  • ATSG 5
  • Target Price
  • AKRO $76.29
  • ATSG $20.60
  • AVG Volume (30 Days)
  • AKRO 1.2M
  • ATSG 1.7M
  • Earning Date
  • AKRO 05-09-2025
  • ATSG 05-05-2025
  • Dividend Yield
  • AKRO N/A
  • ATSG N/A
  • EPS Growth
  • AKRO N/A
  • ATSG N/A
  • EPS
  • AKRO N/A
  • ATSG 0.40
  • Revenue
  • AKRO N/A
  • ATSG $1,961,971,000.00
  • Revenue This Year
  • AKRO N/A
  • ATSG $7.04
  • Revenue Next Year
  • AKRO N/A
  • ATSG $4.43
  • P/E Ratio
  • AKRO N/A
  • ATSG $55.54
  • Revenue Growth
  • AKRO N/A
  • ATSG N/A
  • 52 Week Low
  • AKRO $17.86
  • ATSG $11.69
  • 52 Week High
  • AKRO $58.40
  • ATSG $22.49
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 43.61
  • ATSG 1.00
  • Support Level
  • AKRO $36.46
  • ATSG $21.98
  • Resistance Level
  • AKRO $39.13
  • ATSG $22.47
  • Average True Range (ATR)
  • AKRO 3.04
  • ATSG 0.06
  • MACD
  • AKRO 0.06
  • ATSG -2.64
  • Stochastic Oscillator
  • AKRO 57.38
  • ATSG 0.00

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About ATSG Air Transport Services Group Inc

Air Transport Services Group Inc along with its subsidiaries operates within the airfreight and logistics industry. It leases aircraft and provides airline operations, ground services, aircraft modification and maintenance, and other support services mainly to the cargo transportation and package delivery industries. The company has two reportable segments namely Cargo Aircraft Management and ACMI Services (Aircraft, Crew, Maintenance, and Insurance). It generates a majority of its revenue from the ACMI services segment.

Share on Social Networks: